Pfizer and BioNTech Publish Results of Study
Showing COVID-19 Vaccine Elicits Antibodies that Neutralize Pseudovirus Bearing the SARS-CoV-2 U.K. Strain Spike Protein in Cell Culture Today, Pfizer Inc. (NYSE: PFE) and BioNTech […]
COVID-19
Statement regarding European Commission’s Proposal to Purchase Additional Doses of BioNTech-Pfizer Vaccine
We are in talks with the European Commission (EC) about an amendment to our existing supply agreement for COMIRNATY®, the Pfizer-BioNTech COVID-19 Vaccine. The amendment […]
An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation
Associated with Rapid Transmission Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study conducted by Pfizer and […]
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in […]
Merck Acquires AmpTec to Expand mRNA Capabilities for Vaccines, Treatments and Diagnostics
Merck today announced the acquisition of AmpTec a leading Hamburg, Germany-based, mRNA contract development and manufacturing organization (CDMO). • Adds to Merck’s lipid manufacturing expertise, […]
CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV
Companies enter into a collaboration and services agreement Bayer to support CureVac in numerous areas, including development and supply of CVnCoV CureVac benefits from Bayer´s […]
BioNTech Recognizes Employees and Partners for Their Support in Developing Historic Vaccine
BioNTech SE (Nasdaq: BNTX) today wants to express its thanks and gratitude not only to its employees but also to the many partners who have […]
Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, […]
Spain – orders in vaccines
Spain, through the European Union, has signed contracts with seven companies, seven different vaccines, totalling 140 million doses, which would allow 80 million people to […]
Pfizer and BioNTech Receive Authorization in the European Union for COVID-19 Vaccine COMIRNATY
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer […]
Vaccine roll-out to begin, thanks to the EU Strategy for COVID-19 vaccines
Sandra Gallina, Director General of the European Commission’s Directorate General for Health and Food Safety, talks about the imminent roll-out of COVID-19 vaccines. The EU […]
EMA important links on EU process for approval of Covid-19 vaccines
EMA held this virtual meeting to explain the processes for the development, evaluation, approval and safety monitoring of COVID-19 vaccines in the EU, including EMA’s […]